While most of the funding for biotech startups developing novel therapeutics has stalled in the past year as VCs take a more conservative approach and focus on companies already generating revenue through multiple streams, demand for therapies has not decreased.

The word ‘protein’ often makes one think of a steak dinner or a smoothie, but in the world of biotech protein therapeutics are forming the backbone of next-generation therapies and novel medicines…